Chemtrak reclaims marketing of OTC cholesterol test from Johnson & Johnson.
This article was originally published in The Tan Sheet
Executive Summary
CHEMTRAK CUTS PRICE, REGAINS MARKETING RIGHTS FOR OTC CHOLESTEROL TEST from Johnson & Johnson following disappointing sales of the product under an exclusive North American marketing agreement with J&J's Advanced Care Products (ACP) subsidiary. In an attempt to boost sales of the home cholesterol test kit, ChemTrak has taken over marketing the kit and has initiated several new sales strategies, including lowering its price.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning